Sort by
Refine Your Search
-
, cancerous or developmental diseases. Under the supervision of SysMics scientific leaders, we expect junior postdoctoral fellows to develop their own research projects while acquiring additional academic
-
via an interaction with the RIPK2 protein. (Fulda, Clin Cancer Res, 2015) The design of molecules that disrupt the XIAP/RIPK2 interaction could lead to the development of original and more selective
-
the development of new cancer therapies. Few UBE2N inhibitors have been described in the literature, and these are mainly covalent inhibitors, which, due to a lack of selectivity, expose patients
-
ReGroStaFT, which develops rigorous mathematical approaches to renormalization and coarse-graining for models from statistical physics, particle systems, and stochastic partial differential equations
-
at exploring the evolution of types of warfare that targeted the enemy’s civil population, focusing on (1) aerial bombardment, and civil defense (2) food blockades, and home front campaigns to ration food, and